5 Amendments of Antonyia PARVANOVA related to 2010/2153(INI)
Amendment 36 #
Motion for a resolution
Recital D
Recital D
D. whereas the expenditure committed by the Member States to the response plans drawn up is mainly in connection with the purchase of vast quantities of vaccines, and antiviral treatments, and whereas purchasing procedures have led to serious concerns in terms of transparency and public procurement rules compliance in several Member States
Amendment 47 #
Motion for a resolution
Recital E
Recital E
E. whereas this systematice effectiveness of systematic influenza vaccination strategy ies bhased essentially on an approach that relies on blind faith also been questioned, opening the effectiveness of influenza vaccines, without taking into account scientific data that contradict that belief (see Cochrane journals), and the majority of the studies available on the efficacy of the medicinal products, including vaccines, have been conducted by pharmaceutical companies, meaning that no objective proof has been provided of the efficacy ofdebate on the systematic vaccination approach and the need to further assess the efficacy of strategies to effectively combat seasonal and extraordinary influenza vaccines,outbreaks
Amendment 67 #
Motion for a resolution
Recital I b (new)
Recital I b (new)
Ib. Whereas information and communication around H1N Influenza in 2009-2010 in the EU have demonstrated the crucial role played by media in relaying public health precautions and recommendations, but also in emphasizing selected aspects of the outbreak and its consequences - such as the events of death - without necessarily and systematically putting them into perspective, thus potentially altering public opinion perceptions and public authorities responses
Amendment 103 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls for an immediate clarificationsassessment onf the effectiveness of the H1N1 influenza vaccination strategiesy recommended in the EU, given the weight of evidence casting doubtat EU level and developed by Member States, including a detailed evaluation onf their cost-effectiveness, of the absence of reliable data guaranteeing that effectiveness and the lingering uncertainties surrounding their benefit-risk profile;measures taken and activities implemented, also taking into account the risk-benefit profile of the different approaches and strategies in fighting extraordinary influenza outbreaks
Amendment 154 #
Motion for a resolution
Paragraph 10 e (new)
Paragraph 10 e (new)
10e. Recommends EMA and ECDC to develop targeted communication toolkits and organise specific information sessions in order to further sensitise journalists and media professionals on the issue of pandemic and communicable diseases managements at local, national and international level